FIELD: organic chemistry.
SUDSTANCE: the invention relates to the field of organic chemistry, namely to a method for obtaining a compound of formula (1) or its salt, including (a) the interaction of the compound of formula (8) or its salt with bis(pinacolato)diborone and Pd(dppf)Cl2 to obtain a compound of formula (9) or its salts; (b) reacting a compound of formula (9) or a salt thereof with a compound of formula (10) or a salt thereof with Pd(PPh3)4 and K3PO4 to give a compound of formula (11) or a salt thereof; (c) reacting a compound of formula (11) or a salt thereof with a compound of formula (6) or a salt thereof to give a compound of formula (12) or a salt thereof; and (d) deprotecting a compound of formula (12) or a salt thereof to give a compound of formula (1) or a salt thereof, wherein deprotection of a compound of formula (12) to give a compound of formula (1) comprises reacting a compound of formula (12) with pure TFA.
EFFECT: a new method for obtaining a highly pure compound of formula (1) useful in the treatment of diseases associated with Wnt has been developed.
46 cl, 58 dwg, 33 tbl, 5 ex
Title |
Year |
Author |
Number |
4-[2-[[5-METHYL-1-(2-NAPHTHALINYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE POLYMORPH AND SOLVATES |
2011 |
- Berenger Majmo Ramon
- Medrano Ruperes Khorkhe
- Benet Bukhkhol'Ts Khordi
- Puig Fernandes Laura
- Pellekha Pukseu Laja
|
RU2560150C2 |
NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID |
2011 |
|
RU2612556C2 |
POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION AND PHARMACEUTICAL USES THEREOF |
2014 |
|
RU2658009C2 |
CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL][3-HYDROXY-3-(PIPERIDINE-2-YL)AZETIDINE-1-YL]METHANONE |
2016 |
|
RU2762181C2 |
POLYMORPHIC FORM OF [5-FLUORINE-3-({ 2-[(4-FLUOROBENZENE) SULFONYL]PYRIDINE-3-YL} METHYL)-2-METHYLINDOLE-1-YL]-ACETIC ACID |
2015 |
- Grosse-Sender Katya
- Khilfiker Rolf
|
RU2751319C2 |
CRYSTALLINE FORM (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROSULPHATE |
2015 |
- Errigo Alisha B.
- Dzhuengst Derrik
- Shakh Khalid
|
RU2723990C2 |
3-[1,2,3,6-TETRAHYDROPYRIDIN-2-YL]PYRIDINE GLUTARATE OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF |
2019 |
|
RU2823979C2 |
NEW CRYSTAL SOLID COMPOUND OF 3-PHENYL-4-PROPYL-1-(PYRIDINE-2-YL)-1H-PYRAZOL-5-OL HYDROCHLORIDE |
2018 |
- Moon, Sung Hwan
- Lee, Soo Jin
- Lee, Sung Chan
|
RU2754255C2 |
CRYSTALLINE POLYMORPHYL OF 4-[5-(PYRIDINE-4-YL)-1H-1,2,4-TRIAZOL-3-YL]-PYRIDINE-2-CARBONITRILE AND METHOD OF ITS OBTAINING |
2013 |
- Ivabuti Josiyuki
- Miyata Satikho
- Sato Takakhiro
- Uda Dzunitiro
- Kandou Takamitsu
- Inoue Tadasi
- Nakano Khiroyuki
|
RU2639149C2 |
POLYMORPHOUS FORM OF [5-FLUORO-3-({2-[(4-FLUOROBENZENE) SULPHONYL]PYRIDIN-3-YL}METHYL)-2-METHYLINDOLE-1-YL]-ACETIC ACID |
2015 |
- Khilfiker Rolf
- Grosse-Sender Katya
|
RU2702343C2 |